News & Insights | Access & Channel

This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

FTC calls out significant markups by PBMs in the specialty generic drug market

Attention to PBM vertical integration will continue through 2025

Data show drug shortages are bigger than ever

2025: Continued chaos at the retail pharmacy level

HOSP names new president

How data privacy impacts your copay programs

2025 access trends

Xevant launches GLP-1 Dashboard to tackle rising therapy costs

Surescripts and TPG partner to address healthcare challenges

Collaboration in copay: a new era for patient affordability in healthcare

GoodRx to offer pay-over-time option on select meds

MAP Group expands European reach with SKC acquisition

Examining copay adjustment programs

Lackluster patient experiences in access programs

Medicaid in focus

Key factors to consider when creating efficient hub models

Common pitfalls in 340B audits (and how to avoid them)

Enhancing patient solutions in a dynamic healthcare landscape

State of the states

CAAP bans benefit patients

Quick Links